Game-based Education for Type 1 Diabetes in Children

This study is testing a mobile app video game called DVx-T1D™ to see if it can help children aged 6 to 12 with Type 1 Diabetes (T1D) manage their condition better. The game aims to teach healthy eating and activity habits through a fun, AI-powered cartoon style. Researchers want to see if playing the game for 20 minutes or more daily can improve blood sugar control (measured by HbA1c values and glucose levels). You could join if you are 6-12 years old, have had T1D for at least a year, use insulin, and check your blood sugar regularly. The study is currently recruiting 80 participants.

Study design
This is an interventional study where 80 participants will be randomly assigned to either receive a tablet with the DVx-T1D™ game or continue with their usual care. Both groups will continue to receive standard medical treatment.
What's involved
You would be asked to play the DVx-T1D™ game for 20 minutes or more daily if in the intervention group. You would also maintain food and activity logs, answer questionnaires, and attend evaluations at the start and after three months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be evaluated at the start of the study and again after three months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06264258

Game-based Pediatric Diabetes Education

UNKNOWN
NAAges 6–12InterventionalSupportive care
Carnegie Mellon University
~80 participants
Updated 2025-02-12 on ClinicalTrials.gov
What's tested:DVx-T1D™ app

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in HbA1c values and and insulin dose adjusted HbA1c before and after the intervention
Measured over Three months
+1 more outcome measured
Diabetes Mellitus, Type 1
Behavior, Health
1 sites across 1 states
Pennsylvania1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Children with type 2 diabetes, cystic fibrosis related diabetes, or secondary diabetes.
  • Change in HbA1c values and and insulin dose adjusted HbA1c before and after the interventionThree months

    Change in HbA1C level and insulin dose adjusted HbA1c from baseline to 3 months.

  • Change in glucose average and variabilityThree months

    Change in glucose average and variability as assessed by mean glucose and standard deviation (SD) as well as other continuous glucose monitor (CGM) parameters for those using this device.